NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Tyrosine Allergoid Paediatric and Adult Study

Active Not RecruitingN/A

Sponsor: Allergy Therapeutics

Conditions: Allergic Rhinitis Due to Pollen, Allergic Conjunctivitis, Allergic Asthma

Interventions: MATA trees or MATA grass

Countries: Germany

The primary objective of this 5-year study is to demonstrate non-inferiority of children compared to adults by exploring long-term effectiveness after treatment with TA Bäume (trees) and TA Gräser (grass) following a perennial posology.

Eligibility overview

Sex: ALL

Age: 5 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients from 5 years of age who are treated with TA Gräser top or TA Bäume top due to rhinitis, conjunctivitis and/or mild to moderate bronchial asthma, which are caused by an IgE-mediated allergy to grass and rye pollen or birch, alder and hazel pollen according to the respective SmPC.
* Patients will only be included in this study after the decision on the treatment has been made.

Exclusion Criteria:

* History of allergen-specific immunotherapy (SIT) for trees or grass within the last 5 years
* If it´s intended to treat the patient with only a preseasonal therapy
* A patient should also not be included in the presence of any of the conditions listed in the respective SmPC

Locations (1)

Augsburg, Germany